Grantopen🌐 United StatesPAR-25-057
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institutes of Health
Description
To support UG3/UH3 phased, cooperative agreement research applications to plan and implement clinical trials within the mission of the National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
CFDA: 93.121
Details?
- Posted
- Oct 23, 2024
- Response deadline
- Jan 6, 2028, 5:00 AM UTC (475d)
- Type
- Grant
- Category
- 93.121
- Status
- open
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- PAR-25-057
- Has Description
- true
- Doc Type
- synopsis
- Opp Status
- posted
Contact
National Institutes of Health
grantsinfo@nih.govSimilar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 116,000+ open bids from 2,400+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.